RTSL OTC
Rapid Therapeutic Science Laboratories, Inc.
1W: +0.0%
1M: +0.0%
3M: +300.0%
YTD: -80.0%
1Y: -86.7%
3Y: -99.9%
5Y: -99.9%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$1M
+47.9% ▲
Capital Expenditures
$39K
+86.6% ▲
Free Cash Flow
-$1M
+52.4% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$192K
+37.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2016 | FY2017 | FY2019 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$22K | -$3M | -$349K | -$3M | -$2M |
| Depreciation & Amort. | $0 | $16K | $38K | $56K | $24K |
| Stock-Based Comp. | $0 | $7K | $43K | $20K | $20K |
| Change in Working Capital | -$227 | $29K | $199K | $67K | $200K |
| Other Non-Cash Items | $0 | $2M | -$45K | $1M | $399K |
| Operating Cash Flow | -$22K | -$130K | -$107K | -$2M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | -$39K | -$155K | -$293K | -$39K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | -$39K | -$155K | -$293K | -$39K |
| — Financing Activities — | |||||
| Net Debt Issuance | — | — | — | — | — |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $20K | $172K | $21K | $0 | $1M |
| Financing Cash Flow | $20K | $173K | $96K | $2M | $998K |
| Net Change in Cash | -$2K | $5K | -$11K | -$307K | -$192K |
| Cash End of Period | $7K | $12K | $1K | $192K | $0 |
| Free Cash Flow | -$22K | -$168K | -$262K | -$3M | -$1M |